We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTRG:NYSEEssential Utilities, Inc. Analysis

Data as of 2026-05-11 - not real-time

$37.47

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Essential Utilities (WTRG) trades at a forward P/E of 15.6, well below the industry average of 21.7, suggesting an undervalued position. The stock offers a 3.66% dividend yield with a payout ratio around 70%, which remains sustainable given its regulated cash flow, although free cash flow is currently reported as zero. Recent Q1 earnings missed consensus, reporting $0.83 EPS versus the $1.01 estimate, and the MACD shows bearish momentum while the RSI sits at 36, indicating modest downside pressure. Nonetheless, the company has expanded its customer base by acquiring the Greenville Municipal Water Authority for $18 million, supporting the management's outlook of 5‑7% EPS growth through Q1 2027.
Technically, the price sits just above the identified support level of $36.80 and below the resistance at $40.62, offering an upside potential of roughly 8% to the median analyst target of $41. Volatility over the past 30 days is elevated at 23%, but beta is negative (-0.36), reflecting limited correlation with broader market moves. Given the neutral trend, decreasing volume, and the company’s strong dividend and acquisition-driven growth, the stock merits a cautious buy‑hold stance across horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Q1 earnings miss and bearish MACD
  • Proximity to support level and limited upside
  • Attractive dividend yield

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued valuation relative to peers
  • 5‑7% EPS growth outlook and recent acquisition
  • Stable regulated revenue base

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Defensive utility sector with consistent dividend
  • Long‑term growth from customer base expansion
  • Low beta and limited currency exposure

Key Metrics & Analysis

Financial Health

Revenue Growth10.00%
Profit Margin21.82%
P/E Ratio19.1
ROE8.34%
ROA2.91%
Debt/Equity122.20
P/B Ratio1.5
Industry P/E21.7

Technical Analysis

TrendNeutral
RSI36.3
Support$36.80
Resistance$40.62
MA 20$38.80
MA 50$39.78
MA 200$39.11
MACDBearish
VolumeDecreasing
Fear & Greed Index90.73

Valuation

Target Price$40.40
Upside/Downside7.82%
GradeUndervalued
TypeBlend
Dividend Yield3.66%

Risk Assessment

Beta-0.36
Volatility23.37%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.